164 related articles for article (PubMed ID: 33861622)
1. Safety of image-guided radiotherapy in definitive radiotherapy for localized prostate cancer: a population-based analysis.
Kuo YH; Liang JA; Chen GH; Li CC; Chien CR
Br J Radiol; 2021 May; 94(1121):20200456. PubMed ID: 33861622
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of image-guided radiotherapy for rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy: A population-based propensity score-matched analysis.
Li CC; Liang JA; Chen WT; Chien CR
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e197-e203. PubMed ID: 31250970
[TBL] [Abstract][Full Text] [Related]
3. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.
Mohammed N; Kestin L; Ghilezan M; Krauss D; Vicini F; Brabbins D; Gustafson G; Ye H; Martinez A
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):204-12. PubMed ID: 21167653
[TBL] [Abstract][Full Text] [Related]
4. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy.
Kuo YH; Fang HY; Lin YS; Lein MY; Yang CY; Ho SC; Li CC; Chien CR
Thorac Cancer; 2020 Jan; 11(1):113-119. PubMed ID: 31742897
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of image-guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy.
Liang JA; Tu CY; Hsia TC; Fang HY; Li CC; Chien CR
Thorac Cancer; 2020 Sep; 11(9):2639-2649. PubMed ID: 32725779
[TBL] [Abstract][Full Text] [Related]
7. Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.
Nakamura K; Mizowaki T; Inokuchi H; Ikeda I; Inoue T; Kamba T; Ogawa O; Hiraoka M
Int J Clin Oncol; 2018 Feb; 23(1):158-164. PubMed ID: 28756594
[TBL] [Abstract][Full Text] [Related]
8. Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786).
Vigneault E; Morton G; Parulekar WR; Niazi TM; Springer CW; Barkati M; Chung P; Koll W; Kamran A; Monreal M; Ding K; Loblaw A
Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):527-533. PubMed ID: 29903505
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Image-Guided Radiotherapy in Adjuvant Radiotherapy on Survival for Localized Breast Cancer: A Population-Based Analysis.
Liang JA; Lee PC; Ku CP; Chen WT; Chung CY; Kuo YC; Chou SH; Li CC; Chien CR
Cancer Manag Res; 2021; 13():3465-3472. PubMed ID: 33907469
[TBL] [Abstract][Full Text] [Related]
10. Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.
de Crevoisier R; Bayar MA; Pommier P; Muracciole X; Pêne F; Dudouet P; Latorzeff I; Beckendorf V; Bachaud JM; Laplanche A; Supiot S; Chauvet B; Nguyen TD; Bossi A; Créhange G; Lagrange JL
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1420-1429. PubMed ID: 30071296
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients.
Marina O; Gustafson GS; Kestin LL; Brabbins DS; Chen PY; Ye H; Martinez AA; Ghilezan MI; Wallace M; Krauss DJ
Brachytherapy; 2014; 13(1):59-67. PubMed ID: 23871661
[TBL] [Abstract][Full Text] [Related]
12. Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy.
Gill S; Thomas J; Fox C; Kron T; Rolfo A; Leahy M; Chander S; Williams S; Tai KH; Duchesne GM; Foroudi F
Radiat Oncol; 2011 Oct; 6():145. PubMed ID: 22035354
[TBL] [Abstract][Full Text] [Related]
13. Volumetric-Modulated Arc Radiotherapy with Daily Image-Guidance Carries Better Toxicity Profile for Higher Risk Prostate Cancer.
Ghanem AI; Elsaid AA; Elshaikh MA; Khedr GA
Asian Pac J Cancer Prev; 2021 Jan; 22(1):61-68. PubMed ID: 33507680
[TBL] [Abstract][Full Text] [Related]
14. Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.
Vesprini D; Catton C; Jacks L; Lockwood G; Rosewall T; Bayley A; Chung P; Gospodarowicz M; Ménard C; Milosevic M; Nichol A; Skala M; Warde P; Bristow RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):608-16. PubMed ID: 22099034
[TBL] [Abstract][Full Text] [Related]
15. Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy.
Valeriani M; Bracci S; Osti MF; Falco T; Agolli L; De Sanctis V; Enrici RM
Radiat Oncol; 2013 Jun; 8():137. PubMed ID: 23759081
[TBL] [Abstract][Full Text] [Related]
16. Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.
Wang D; Zhang Q; Eisenberg BL; Kane JM; Li XA; Lucas D; Petersen IA; DeLaney TF; Freeman CR; Finkelstein SE; Hitchcock YJ; Bedi M; Singh AK; Dundas G; Kirsch DG
J Clin Oncol; 2015 Jul; 33(20):2231-8. PubMed ID: 25667281
[TBL] [Abstract][Full Text] [Related]
17. Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT.
Guckenberger M; Lawrenz I; Flentje M
Strahlenther Onkol; 2014 Jan; 190(1):48-53. PubMed ID: 24196279
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of image-guided radiotherapy for non-operated localized esophageal squamous cell carcinoma patients receiving concurrent chemoradiotherapy: A population-based propensity score matched analysis.
Li CC; Chen CY; Chien CR
Oncotarget; 2016 Nov; 7(44):71548-71555. PubMed ID: 27689398
[TBL] [Abstract][Full Text] [Related]
19. Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer.
Schumacher LD; Dal Pra A; Hoffe SE; Mellon EA
Br J Radiol; 2020 Oct; 93(1114):20200028. PubMed ID: 32783629
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study.
Tramacere F; Arcangeli S; Pignatelli A; Castagna R; Portaluri M
Anticancer Res; 2015 May; 35(5):3049-54. PubMed ID: 25964594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
